
Millions of people in the UK who take drugs for attention deficit hyperactivity disorder (ADHD) are facing difficulties getting their prescriptions filled due to shortages. These shortages are currently affecting four of the five types of medicine licensed in the UK to treat ADHD. Certain products and dosages may be more affected than others.
This severe disruption in supply is taking a toll on many peoples’ mental health and wellbeing and negatively affecting their daily life. Fortunately, it’s expected these shortages will be resolved by the end of 2023.